Cleared Traditional

K072593 - A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS SYSTEM AND PC SOFTWARE

K072593 is an FDA 510(k) clearance for A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS..., manufactured by Healthstats International Pte. , Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K072593 · Healthstats International Pte. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
62d
Days
Class 2
Risk

K072593 is an FDA 510(k) clearance for the A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS SYSTEM AND PC SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Healthstats International Pte. , Ltd. (Egale, US). The FDA issued a Cleared decision on November 15, 2007 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Healthstats International Pte. , Ltd. devices

FDA 510(k) Submission Details - K072593

510(k) Number K072593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2007
Decision Date November 15, 2007
Days to Decision 62 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 125d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1031
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K072593.
AVITA BLUETOOTH BLOOD PRESSURE MONITOR, MODEL: BPM656ZB
K072137 · Avita Corporation · Dec 2007
CONTINUOUS NON-INVASIVE CARDIAC OUTPUT AND BLOOD PRESSURE MONITOR WITH REAL-TIME HEMODYNAMICS
K072049 · Bmeye B.V. · Nov 2007
MOBIL-O-GRAPH NG 24 H ABP-CONTROL
K072446 · I.E.M. GmbH · Nov 2007
MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901
K071384 · Nihon Seimitsu Sokki Co., Ltd. · Oct 2007
HONEYWELL HOMMED CENTRAL STATION 4.0
K072272 · Honeywell Hommed, LLC · Sep 2007
KD-795 WRIST MEASUREMENT ELECTRONIC BLOOD PRESSURE MONITOR
K070826 · Kodon(Tianjin)Electronic&Electrical Apparatus Co., · Aug 2007